Brikell, Isabell

Incidence rates and cumulative incidences of the full spectrum of diagnosed mental disorders in childhood and adolescence

Dalsgaard, S., Thorsteinsson, E., Trabjerg, B. B., Schullehner, J., Plana-Ripoll, O., Brikell, I., Wimberley, T., Thygesen, M., Madsen, K. B., Timmerman, A., et al. (2020) · JAMA Psychiatry

Child and Adolescent Psychosocial and Emotional DevelopmentMental Health Treatment and Access

Cited by 510

Attention-deficit/hyperactivity disorder

Faraone, S. V., Bellgrove, M. A., Brikell, I., Cortese, S., Hartman, C. A., Hollis, C., Newcorn, J. H., Philipsen, A., Polanczyk, G. V., Rubia, K., et al. (2024) · Nature Reviews Disease Primers

Attention Deficit Hyperactivity DisorderAutism Spectrum Disorder Research

Cited by 355

The familial co-aggregation of ASD and ADHD: a register-based cohort study

Ghirardi, L., Brikell, I., Kuja-Halkola, R., Freitag, C. M., Franke, B., Asherson, P., Lichtenstein, P., & Larsson, H. (2018) · Molecular Psychiatry

Autism Spectrum Disorder ResearchAttention Deficit Hyperactivity Disorder

Cited by 220

Association of Genetic Risk Factors for Psychiatric Disorders and Traits of These Disorders in a Swedish Population Twin Sample

Taylor, M. J., Martin, J., Lu, Y., Brikell, I., Lundström, S., Larsson, H., & Lichtenstein, P. (2019) · JAMA Psychiatry

Genetic Associations and EpidemiologySchizophrenia research and treatment

Cited by 174

Association of prenatal exposure to valproate and other antiepileptic drugs with risk for attention-deficit/hyperactivity disorder in offspring

Christensen, J., Pedersen, L., Sun, Y., Dreier, J. W., Brikell, I., & Dalsgaard, S. (2019) · JAMA Network Open

Pharmacological Effects and Toxicity StudiesAttention Deficit Hyperactivity Disorder

Cited by 127

The contribution of common genetic risk variants for ADHD to a general factor of childhood psychopathology

Brikell, I., Larsson, H., Lu, Y., Pettersson, E., Chen, Q., Kuja-Halkola, R., Karlsson, R., Lahey, B. B., Lichtenstein, P., & Martin, J. (2020) · Molecular Psychiatry

Attention Deficit Hyperactivity DisorderGenetic Associations and Epidemiology

Cited by 126

Familial liability to epilepsy and attention-deficit/hyperactivity disorder: a nationwide cohort study

Brikell, I., Ghirardi, L., D’Onofrio, B. M., Dunn, D. W., Almqvist, C., Dalsgaard, S., Kuja-Halkola, R., & Larsson, H. (2018) · Biological Psychiatry

Attention Deficit Hyperactivity DisorderEpilepsy research and treatment

Cited by 85

Genetic association study of childhood aggression across raters, instruments, and age

Ip, H. F., van der Laan, C. M., Krapohl, E. M. L., Brikell, I., Sánchez-Mora, C., Nolte, I. M., St Pourcain, B., Bolhuis, K., Palviainen, T., Zafarmand, H., et al. (2021) · Translational Psychiatry

Genetic Associations and EpidemiologyNeurotransmitter Receptor Influence on Behavior

Cited by 71

Attention-deficit/hyperactivity disorder is associated with increased risk of cardiovascular diseases: a systematic review and meta-analysis

Li, L., Yao, H., Zhang, L., Garcia‐Argibay, M., Du Rietz, E., Brikell, I., Solmi, M., Cortese, S., Ramos‐Quiroga, J. A., Ribasés, M., et al. (2023) · JCPP Advances

Attention Deficit Hyperactivity DisorderCardiovascular Health and Risk Factors

Cited by 55

The association between type 2 diabetes and attention- deficit/hyperactivity disorder: a systematic review, meta-analysis, and population-based sibling study

Garcia-Argibay, M., Li, L., Du Rietz, E., Zhang, L., Yao, H., Jendle, J., Ramos-Quiroga, J. A., Ribasés, M., Chang, Z., Brikell, I., et al. (2023) · Neuroscience & Biobehavioral Reviews

Attention Deficit Hyperactivity DisorderDiabetes Management and Research

Cited by 52

Risk variants and polygenic architecture of disruptive behavior disorders in the context of attention-deficit/hyperactivity disorder

Demontis, D., Walters, R. K., Rajagopal, V. M., Waldman, I. D., Grove, J., Als, T. D., Dalsgaard, S., Ribasés, M., Bybjerg-Grauholm, J., Bækvad-Hansen, M., et al. (2021) · Nature Communications

Attention Deficit Hyperactivity DisorderGenetic Associations and Epidemiology

Cited by 50

Attention-deficit/hyperactivity disorder and major depressive disorder: evidence from multiple genetically informed designs

Garcia-Argibay, M., Brikell, I., Thapar, A., Lichtenstein, P., Lundström, S., Demontis, D., & Larsson, H. (2024) · Biological Psychiatry

Attention Deficit Hyperactivity DisorderGenetic Associations and Epidemiology

Cited by 33

Evaluating ADHD medication trial representativeness: a Swedish population-based study comparing hypothetically trial-eligible and trial-ineligible individuals

Garcia-Argibay, M., Chang, Z., Brikell, I., Kuja-Halkola, R., D'Onofrio, B. M., Lichtenstein, P., Newcorn, J. H., Faraone, S. V., Larsson, H., & Cortese, S. (2025) · The Lancet Psychiatry

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 31

Continuity of Genetic Risk for Aggressive Behavior Across the Life-Course

van der Laan, C. M., Morosoli-García, J. J., van de Weijer, S. G. A., Colodro-Conde, L., the ACTION Consortium, Ip, H. F., van der Laan, C. M., Krapohl, E. M. L., Brikell, I., Sánchez-Mora, C., et al. (2021) · Behavior Genetics

Genetic Associations and EpidemiologyNeurotransmitter Receptor Influence on Behavior

Cited by 24